(Q46344528)

21 December 2017

title

Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination (English)

1 reference

21 December 2017

1 reference

2

1 reference

21 December 2017

Sally Pimlott

3

1 reference

21 December 2017

author name string

A G McCluskey

1

1 reference

21 December 2017

J W Babich

4

1 reference

21 December 2017

M N Gaze

5

1 reference

21 December 2017

R J Mairs

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

21 December 2017

British Journal of Radiology

published in

1 reference

21 December 2017

volume

81 Spec No 1

1 reference

21 December 2017

page(s)

S28-35

1 reference

21 December 2017

Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction

cites work

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Topoisomerase I inhibitors: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Inhibition of radiation-induced neoplastic transformation by beta-lapachone

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde?

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Enhanced fidelity for rejoining radiation-induced DNA double-strand breaks in the G2 phase of Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F27723093

21 January 2018

Identifiers

DOI

10.1259/BJR/27723093

1 reference

21 December 2017

1 reference

21 December 2017